Fundz
Back to Investors

Track Eli Lilly And Company's Investment Activity

Get real-time alerts when Eli Lilly And Company makes new investments. Full investor profiles, co-investor networks, and deal history are available on Pro plans.

Compare PlansProFull access from $49/mo
E

Eli Lilly And Company

Corporate VC
Total Deals
32
Recent (90d)
6
Total Capital
$3.4B
Co-Investors
177
R

Ratio Therapeutics

BiotechnologyBoston, United States
series c
$70.0M

Jul 31, 2026

F

Flare Therapeutics

BiotechnologyCambridge, United States
series c
$85.0M

Jun 30, 2026

L

Lycia Therapeutics, Inc.

Biotechnology
series d
$75.0M

Jun 25, 2026

T

TRIMTECH Therapeutics

BiotechnologyCambridge, United Kingdom
seed
$47.0M

Jun 23, 2026

T

TRIMTECH Therapeutics

BiotechnologyCambridge, United Kingdom
seed
$14.0M

Jun 23, 2026

27+ more investments

View all 32 deals by Eli Lilly And Company

ProFull deal history requires Pro

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. Trusted by firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz tracks 200,000+ companies and 40,000+ investors.